Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic
A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
See Screening Protocol LUNGMAP
Cohort 1 (patients with squamous cell lung cancer) permanently closed to accrual effective November 15, 2020.
Cohort 2 (patients with non-squamous cell lung cancer) is temporarily closed effective April 6, 2020.